Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome

NCT06538181 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic Syndrome
VEXAS
Vexas Syndrome

Interventions

DRUG: Pacritinib

Sponsor

Washington University School of Medicine

Collaborators

[object Object]